Compounding
Disclosure
Committed to the highest standards of safety, quality, and pharmaceutical integrity.
Pharmaceutical Excellence
NovaGLP1 works exclusively with PCAB-accredited (Pharmacy Compounding Accreditation Board) or high-volume 503B outsourcing facilities when possible. These pharmacies are subject to higher levels of oversight and quality standards.
Compounded Semaglutide and Tirzepatide provided through our platform are the same active chemical base as the brand-name versions, prepared in a personalized concentration for our patients.
Quality Guarantee
100% Third-Party Lab Verified
What is Compounding?
Pharmaceutical compounding is the creation of a personalized medication by a licensed pharmacist to meet the unique needs of an individual patient when an FDA-approved drug may not be appropriate or available.
Sourcing & Purity
We only partner with State Board of Pharmacy-licensed compounding pharmacies that use high-quality active pharmaceutical ingredients (API) sourced from FDA-registered facilities.
Safety Standards
Our pharmacy partners adhere to USP <797> and <795> standards for sterile and non-sterile compounding, ensuring every dose is prepared in a controlled, clean-room environment.
Testing & Quality
Every batch of medication undergoes rigorous third-party testing for potency, sterility, and endotoxins before it is released for shipment to our patients.
FDA Regulation
Compounded drugs are not FDA-approved. This means that the FDA does not review compounded drug applications for safety, effectiveness, or quality before they are marketed.
Patient Suitability
Compounded GLP-1 medications are prescribed by licensed physicians only when they determine it is medically necessary for the specific patient's health needs.
FDA Statement
"Compounded drugs are not FDA-approved. This means that FDA does not review compounded drug applications for safety, effectiveness, or quality before they are marketed. Compounded drugs can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug, such as a patient who has an allergy to a specific ingredient in an FDA-approved drug or a patient who cannot swallow a pill and needs a medicine in liquid form."
Source: US Food and Drug Administration (FDA)